ArticleTherapeutic innovation & regulatory science2026

Advancing Platform Trials in Early Oncology by Using MATS and EXNEX in Randomized Controlled Trials.

Zhe Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.